Healing cranial defects with AdRunx2-transduced marrow stromal cells

Journal of Dental Research

Volumn 86, Issue 12, 2007, Pages 1207-1211

  Zhao, Z ^a,b   Wang, Z ^a   Ge, C ^b   Krebsbach, P ^a   Franceschi, R T ^b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adenovirus; Bone; Gene therapy; Regeneration; Runx2; Stem cells

Indexed keywords

RUNX2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE REGENERATION; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GENETICS; MALE; METABOLISM; METHODOLOGY; MOUSE; OSTEOBLAST; SKULL; STEM CELL TRANSPLANTATION; STROMA CELL; TRANSPLANTATION; WOUND HEALING;

ANIMALS; BONE MARROW CELLS; BONE REGENERATION; CELL DIFFERENTIATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE THERAPY; GENE TRANSFER TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; OSTEOBLASTS; OSTEOGENESIS; SKULL; STEM CELL TRANSPLANTATION; STROMAL CELLS; TRANSDUCTION, GENETIC; WOUND HEALING;

EID: 37549048980     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910708601213     Document Type: Article

References (31)

1. Asahara T, Kalka C, Isner JM (2000). Stem cell therapy and gene transfer for regeneration. Gene Ther 7:451-457.
2. Bianco P, Riminucci M, Gronthos S, Robey PG (2001). Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19:180-192.
3. Blyth K, Terry A, Mackay N, Vaillant F, Bell M, Cameron ER, et al. (2001). Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging. Oncogene 20:295-302.
4. Boyan BD, Hummert TW, Dean DD, Schwartz Z (1996). Role of material surfaces in regulating bone and cartilage cell response. Biomaterials 17:137-146.
5. Bruder SP, Fox BS (1999). Tissue engineering of bone. Cell based strategies. Clin Orthop Relat Res 367 (Suppl): S68-S83.
6. Byers BA, Garcia AJ (2004). Exogenous Runx2 expression enhances in vitro osteoblastic differentiation and mineralization in primary bone marrow stromal cells. Tissue Eng 10:1623-1632.
7. Byers BA, Guldberg RE, Hutmacher DW, Garcia AJ (2006). Effects of Runx2 genetic engineering and in vitro maturation of tissue-engineered constructs on the repair of critical size bone defects. J Biomed Mater Res A 76:646-655.
8. Derubeis AR, Cancedda R (2004). Bone marrow stromal cells (BMSCs) in bone engineering: limitations and recent advances. Ann Biomed Eng 32:160-165.
9. Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P (2002). High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Mol Cell Biol 22:6222-6233.
10. Kojima H, Uemura T (2005). Strong and rapid induction of osteoblast differentiation by Cbfa1/Til-1 overexpression for bone regeneration. J Biol Chem 280:2944-2953.
11. Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RV, Rowe DW, Robey PG (1997). Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63:1059-1069.
12. Krebsbach PH, Mankani MH, Satomura K, Kuznetsov SA, Robey PG (1998). Repair of craniotomy defects using bone marrow stromal cells. Transplantation 66:1272-1278.
13. Krebsbach PH, Kuznetsov SA, Bianco P, Robey PG (1999). Bone marrow stromal cells: characterization and clinical application. Crit Rev Oral Biol Med 10:165-181.
14. Liu W, Toyosawa S, Furuichi T, Kanatani N, Yoshida C, Liu Y, et al. (2001). Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol 155:157-166.
15. Lynch MP, Stein JL, Stein GS, Lian JB (1995). The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp Cell Res 216:35-45.
16. Muschler GF, Nitto H, Boehm CA, Easley KA (2001). Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res 19:117-125.
17. Noguchi P (2003). Risks and benefits of gene therapy. N Engl J Med 348:193-194.
18. Oreffo RO, Bord S, Triffitt JT (1998). Skeletal progenitor cells and ageing human populations. Clin Sci (Lond) 94:549-555.
19. Osyczka AM, Diefenderfer DL, Bhargave G, Leboy PS (2004). Different effects of BMP-2 on marrow stromal cells from human and rat bone. Cells Tissues Organs 176:109-119.
20. Park J, Ries J, Gelse K, Kloss F, von der Mark K, Wiltfang J, et al. (2003). Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Gene Ther 10:1089-1098.
21. Rose FR, Oreffo RO (2002). Bone tissue engineering: hope vs hype. Biochem Biophys Res Commun 292:1-7.
22. St George JA (2003). Gene therapy progress and prospects: adenoviral vectors. Gene Ther 10:1135-1141.
23. Takahashi Y, Yamamoto M, Tabata Y (2005). Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and beta-tricalcium phosphate. Biomaterials 26:3587-3596.
24. Tsuda H, Wada T, Ito Y, Uchida H, Dehari H, Nakamura K, et al. (2003). Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol Ther 7:354-365.
25. Turgeman G, Pittman DD, Muller R, Kurkalli BG, Zhou S, Pelled G, et al. (2001). Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J Gene Med 3:240-251.
26. Warren SM, Fong KD, Chen CM, Loboa EG, Cowan CM, Lorenz HP, et al. (2003a). Tools and techniques for craniofacial tissue engineering. Tissue Eng 9:187-200.
27. Warren SM, Greenwald JA, Nacamuli RP, Fong KD, Song HJ, Fang TD, et al. (2003b). Regional dura mater differentially regulates osteoblast gene expression. J Craniofac Surg 14:363-370.
28. Xiao G, Wang D, Benson MD, Karsenty G, Franceschi RT (1998). Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J Biol Chem 273:32988-32994.
29. Yang S, Wei D, Wang D, Phimphilai M, Krebsbach PH, Franceschi RT (2003). in vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res 18:705-715.
30. Zhao M, Zhao Z, Koh JT, Jin T, Franceschi RT (2005a). Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7. J Cell Biochem 95:1-16.
31. Zhao Z, Zhao M, Xiao G, Franceschi RT (2005b). Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo. Mol Ther 12:247-253.